XELEAC 20 – Doxorubicin Hydrochloride Liposome injection 20mg

Description

XELEAC 20

• As monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk.
• For treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen.
• In combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.
• For treatment of AIDS-related Kaposi’s sarcoma (KS) in patients with low CD4 counts (< 200 CD4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease.